Skip to main content
. 2012 Aug 23;11(11):1389–1403. doi: 10.1074/mcp.M112.018861

Fig. 1.

Fig. 1.

Detection of endogenous oxidized and nonoxidized forms of the ApoE4-specific peptide LGADMEDVR in plasma from an AD cohort. B, shows extracted ion chromatograms of SRM transitions 511.3/908.4 (blue) and 514.3/914.4 (red) (monitored for mono-oxidized endogenous LGADM(ox)EDVR and heavy LGADM(ox)EDV*R) and transitions 503.3/892.4 (green) and 506.3/898.4 (gray) (monitored for nonoxidized endogenous LGADMEDVR and heavy LGADMEDV*R) in eight plasma samples. The MS/MS spectra correspond to the doubly protonated mono-oxidized endogenous LGADM(ox)EDVR ion (A) and the doubly protonated nonoxidized endogenous LGADMEDVR ion (C). Sixty-eight plasma samples from ε4 allele-bearing subjects (100 μl each) were selected randomly from the AD cohort and digested by trypsin before monitoring SRM transitions 511.3/908.4 and 503.3/892.4 (tracking oxidized and nonoxidized ApoE4-specific peptide LGADMEDVR, respectively) (D).